Eisai

China - LiaoningBiotechnology5 H-1B visas (FY2023)

Focus: Eisai is a biotechnology company headquartered in China (Liaoning) specializing in small molecule therapeutics across oncology, neurology, immunology, gastroenterology, and metabolic diseases. The company generates 91% of revenue from LENVIMA, a receptor tyrosine kinase inhibitor.

Oncology Neurology Immunology Gastroenterology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Eisai

AI assessmentNot Hiring

No open roles listed right now. Follow Eisai to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

3/9 — Basic

Company HealthWatch

Pipeline

Early-stage

50 total

LOE Risk

2 imminent

ARICEPT

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

LENVIMA

Hepatocellular carcinoma, thyroid cancer, renal cell carcinoma

$779M Part D

Peak

Help build intelligence for Eisai

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Pipeline & Clinical Trials

No Intervention

Gastric Ulcer

N/A

Clinical Trials (1)

NCT02423187Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin

N/A

Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Thera

Arthritis, Rheumatoid

N/A

Clinical Trials (1)

NCT03264703Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Therapy of Conventional Disease-modifying Antirheumatic Drugs (cDMARDs) to cDMARD Plus ANti-TNF Versus cDMARDs in Real World

N/A

Pariet

Stomach Ulcer

N/A

Clinical Trials (1)

NCT05208268A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer

N/A

Usual care setting

Mild Cognitive Impairment

N/A

Clinical Trials (1)

NCT03448445A Study to Evaluate Alzheimer's Disease Conversion Rate Differences Between High-risk Mild Cognitive Impairment (MCI) and Low-risk MCI in a Real World Setting

N/A

fospropofol

Impaired Airway Clearance

N/A

Clinical Trials (1)

NCT01289483Fospropofol for Sedation During Elective Awake Intubation

N/A

No Intervention

Sleep Initiation and Maintenance Disorders

N/A

Clinical Trials (1)

NCT06744673A Study to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control Population

N/A

Non-interventional

Arthritis, Rheumatoid

N/A

Clinical Trials (1)

NCT06246123A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants

N/A

No Intervention

Biliary Tract Cancer

N/A

Clinical Trials (1)

NCT06793709A Post-marketing Observational Study of Tasfygo in Participants With Unresectable Biliary Tract Cancer With Fibroblast Growth Factor Receptor 2 (FGFR2) Fusion Gene Positivity Who Progressed After Chemotherapy

N/A

group cognitive intervention

Mild Cognitive Impairment

N/A

Clinical Trials (1)

NCT01358955Efficacy Study of Cognitive Intervention in Amnestic Mild Cognitive Impairment

N/A

National Pregnancy Registry for Psychiatric Medications

Pregnant Women

N/A

Non-interventional

Endometrial Neoplasms

N/A

Clinical Trials (1)

NCT05375136A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients

N/A

Non-interventional

Liver Neoplasms

N/A

Clinical Trials (1)

NCT05225207A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants

N/A

No intervention

Malignant Glioma

N/A

Clinical Trials (1)

NCT02300506Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma

N/A

No Intervention

Psychotic Disorders

N/A

Clinical Trials (1)

NCT05633108A Study Based on the French National Health Insurance Database in Participants With Psychotic Disorders

N/A

Denileukin diftitox

Cancer

N/A

Clinical Trials (1)

NCT01432483Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak)

N/A

Lorcaserin

Epilepsies, Myoclonic

N/A

Clinical Trials (1)

NCT04457687Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

N/A

Cognigram

Subjective Cognitive Decline

N/A

No intervention

Malignant Glioma

N/A

Clinical Trials (1)

NCT02300532Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)

N/A

This is a registry.

Dementia Disorder

N/A

Non-interventional

Irregular Sleep Wake Rhythm Disorder

N/A

Clinical Trials (1)

NCT04300569A Study to Determine the Signs and Symptoms That Impact Daily Life of Participants With Irregular Sleep-Wake Rhythm Disorder

N/A

No treatment

Epilepsy

N/A

Clinical Trials (1)

NCT02736162Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With Epilepsy

N/A

donepezil

Alzheimer's Disease

N/A

Clinical Trials (1)

NCT01023867Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed Dementia

N/A

A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Pat

Alzheimer's Disease

N/A

Clinical Trials (1)

NCT02262975A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS)

N/A

rabeprazole sodium

Refractory Reflux Esophagitis

N/A

Clinical Trials (1)

NCT01321567Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis

N/A

Lorcaserin

Obesity

N/A

Clinical Trials (1)

NCT02388568Lifestyle Modification and Lorcaserin for Weight Loss Maintenance

N/A

3 Screen Electronic Alert

Deep Vein Thrombosis

N/A

Clinical Trials (1)

NCT005500823 Screen Electronic Alert

N/A

Eslicarbazepine Acetate tablets

Partial Onset Seizures

N/A

Clinical Trials (1)

NCT01830400A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS)

N/A

Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008

Metastatic Breast Cancer

N/A

Post-Marketing Surveillance of Lenvima in Korean Patients

Differentiated Thyroid Carcinoma (DTC)

N/A

Clinical Trials (1)

NCT02764554Post-Marketing Surveillance of Lenvima in Korean Patients

N/A

Surveillance of Humira Injection in Korean Patients

Rheumatoid Arthritis

N/A

Lorcaserin

Obesity

N/A

Clinical Trials (1)

NCT03552107Lorcaserin: Real World Experience in an Insurance-Based Weight Management Clinic

N/A

No Intervention

Multiple Sclerosis, Relapsing-remitting

N/A

Clinical Trials (1)

NCT05366036A Study for Tecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple Sclerosis

N/A

Lenvatinib

Thyroid Cancer

N/A

Clinical Trials (1)

NCT03533361Expanded Access Program With Lenvatinib for the Treatment of Differentiated Thyroid Cancer in Brazil

N/A

Extended Treatment in Metastatic Breast Cancer With Eribulin

Breast Cancer

N/A

Clinical Trials (1)

NCT02769364Extended Treatment in Metastatic Breast Cancer With Eribulin

N/A

Lenvatinib

Carcinoma, Hepatocellular

N/A

Clinical Trials (1)

NCT04763408A Study to Evaluate the Safety and Tolerability of Lenvatinib in Participants With Advanced or Unresectable Hepatocellular Carcinoma

N/A

Eribulin [Halaven] Use For the Treatment of Advanced Breast Cancer

Metastatic Breast Cancer

N/A

Clinical Trials (1)

NCT02790320Eribulin [Halaven] Use For the Treatment of Advanced Breast Cancer

N/A

Tazemetostat

Lymphoma, Follicular

N/A

Clinical Trials (1)

NCT05228158A Study of Tazemetostat on Safety in Participants With Relapsed or Refractory Follicular Lymphoma With Enhancer of Zeste Homolog 2 (EZH2) Gene Mutation in Japan

N/A

Perampanel

Idiopathic Generalized Epilepsy

N/A

Clinical Trials (1)

NCT04252846A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy

N/A

Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Res

Inflammatory Bowel Disease

N/A

Clinical Trials (1)

NCT03264690Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Before and After the Anti-TNF Treatment in IBD Patients

N/A

Dalteparin sodium

Venous Thromboembolism

N/A

Clinical Trials (1)

NCT01050153The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma

N/A

donepezil hydrochloride

Alzheimer's Disease

N/A

Clinical Trials (1)

NCT01129596Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-

N/A

Eribulin Mesylate

Metastatic Breast Cancer

N/A

Clinical Trials (1)

NCT03245112Halaven Patient Registry (Metastatic Breast Cancer, MBC)

N/A

Halaven Post-Marketing Surveillance (PMS)

Breast Cancer

N/A

Clinical Trials (1)

NCT02441764Halaven Post-Marketing Surveillance (PMS)

N/A

Lenvatinib

Thyroid Neoplasms

N/A

Clinical Trials (1)

NCT02430714Post-marketing Surveillance of Lenvatinib Mesylate (Lenvima Capsule) in Patients With Unresectable Thyroid Cancer (Study LEN01T)

N/A

Zonisamide tablets

Partial Onset Seizures

N/A

Clinical Trials (1)

NCT01830868A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410) (ZOOM)

N/A

Perampanel

Partial Seizures

N/A

Clinical Trials (1)

NCT04257604A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures

N/A

Eribulin Use for the Treatment of Advanced Breast Cancer: A Prospective Observational Registry

Breast Cancer

N/A

Clinical Trials (1)

NCT02443428Eribulin Use for the Treatment of Advanced Breast Cancer: A Prospective Observational Registry

N/A

Eribulin

Locally Advanced or Metastatic Breast Cancer

N/A

Clinical Trials (1)

NCT03027245Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy

N/A

ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

Focal Epilepsy

N/A

Clinical Trials (1)

NCT03082222ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

N/A

Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflamma

Lumbar Disc Degenerative Disease

N/A

Clinical Trials (1)

NCT01299077Drug Use Survey (DUS) of Triple Therapy (Methycobal (MBL)+ Myonal (MYO)+ Non-steroidal Anti-inflammatory Drags (NSAID)) on the Symptom Relief of Lumbar DDD in China

N/A

Eisai

About Eisai

Why Work Here

Key Products

Watch Out For

Products & Portfolio (9)

Key Products by Revenue

Other Products (3)

Pipeline & Clinical Trials

Open Jobs (0)

Hiring Trend

Visa Sponsorship